BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Parse Biosciences Acquires Biomage

-Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software ...

January 17, 2024 | News

Complete Genomics and Gencove Partner for Bundled Low-Pass Whole Genome Sequencing Solution at PAG 31

The partnership will combine Gencove's platform for data analytics and management with Complete Genomics' sequencing products and automation capabilit...

January 17, 2024 | News

CMS Grants Favorable Reimbursement for RefleXion’s SCINTIX Therapy

The CMS has established a national payment rate for RefleXion's SCINTIX® biology-guided radiotherapy using CMS' New Technology Ambulatory Payment Class...

January 16, 2024 | News

CARsgen's CT011 Granted NMPA IND Clearance for GPC3-Positive Stage Ⅲa Liver Cancer

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...

January 16, 2024 | News

WuXi Biologics and BioNTech Partner on Monoclonal Antibody Research Agreement

Under the terms of the agreement, WuXi Biologics leverages its proprietary antibody discovery technology platforms (R in CRDMO) to discover two undisclosed...

January 11, 2024 | News

Lotte Biologics Unveils Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024

Richard Lee, CEO of LOTTE BIOLOGICS, delivers a keynote speech at the JPM Healthcare Conference for the second consecutive year Unveils company's b...

January 11, 2024 | News

Novogene Expands Global Presence with Increased PacBio Revio Fleet for Enhanced Long-Read Sequencing Applications

Novogene aims to strengthen its service offerings in long-read sequencing applications with PacBio latest Revio sequencer. As an early adopter of PacBio Re...

January 10, 2024 | News

GC Cell Initiates Phase 1 Trials for AB-201 Cancer Treatment with Lunit AI Platform

GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee (HREC) a...

January 09, 2024 | News

The pioneering clinical implementation of Base Editing Therapy for Hemoglobinopathy on a global scale

On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), using innovative transformer Base Editing (tBE...

January 09, 2024 | News

Shanghai Argo Partners with Novartis in Multi-Program RNAi Licensing and Collaboration

- Argo will receive upfront payments of $185 million from Novartis and is eligible to receive potential option and milestone payments as wel...

January 08, 2024 | News

Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development

Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...

January 08, 2024 | News

Merck Broadens Colorectal Cancer Portfolio via Licensing Deal with Inspirna

First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...

January 05, 2024 | News

IASO BIO Partners with Umoja Biopharma for Cell and Gene Therapies

Under the terms of the collaborations, IASO Bio will receive exclusive access to the rapamycin-activated cytokine receptor (RACR™) platform, Umoja's ...

January 04, 2024 | News

Belief BioMed Completes First Dosing in Hemophilia A Trial

BBM-H803 is Belief BioMed's first gene therapy for the treatment of hemophilia A and is the company's second product which has obtained IND approval from t...

January 04, 2024 | News

Stay Connected